Literature DB >> 28581894

Identification of Small-Molecule Noncovalent Binders Utilizing SAMDI Technology.

Erica C VanderPorten1, Michael D Scholle2, John Sherrill2, John C Tran1, Yichin Liu1.   

Abstract

In recent years, the ability to unambiguously identify complex mixtures of analytes with high accuracy and resolving power in a label-free format continues to expand the application of mass spectrometry (MS) in the drug discovery process. This advantage combined with improved instrumentation makes MS suitable for targets with limited alternative assays for high-throughput screening (HTS). We describe a novel screening format using Self-Assembled Monolayers and matrix-assisted laser Desorption Ionization (SAMDI) technology. SAMDI enables affinity capture of a target protein for use in a small-molecule-binding assay format. Subsequent ionization enables the inferred identification of noncovalent compound interactions. SAMDI technology overcomes shot-to-shot variability by uniformly saturating the surface with captured protein, thereby minimizing matrix crystallization "hot spots." Furthermore, the combination with high-resolution matrix-assisted laser desorption/ionization time of flight significantly reduces interference of small-molecule detection from salt, detergent, and matrix. By using a pooled library format, the SAMDI assay can significantly improve the throughput of MS-based screening irrespective of enzyme activity. Finally, we demonstrate binding affinity rank ordering from a pool of compounds that correlates with potency data from a biochemical assay.

Entities:  

Keywords:  MALDI; SAMDI; mass spectrometry; noncovalent binder

Mesh:

Substances:

Year:  2017        PMID: 28581894     DOI: 10.1177/2472555217712761

Source DB:  PubMed          Journal:  SLAS Discov        ISSN: 2472-5552            Impact factor:   3.341


  3 in total

1.  High-throughput antibody screening from complex matrices using intact protein electrospray mass spectrometry.

Authors:  William S Sawyer; Neha Srikumar; Joseph Carver; Phillip Y Chu; Amy Shen; Ankai Xu; Ambrose J Williams; Christoph Spiess; Cong Wu; Yichin Liu; John C Tran
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-23       Impact factor: 11.205

2.  Label-Free Screening of SARS-CoV-2 NSP14 Exonuclease Activity Using SAMDI Mass Spectrometry.

Authors:  Michael D Scholle; Cheng Liu; Jerome Deval; Zachary A Gurard-Levin
Journal:  SLAS Discov       Date:  2021-04-17       Impact factor: 3.341

3.  Label-free duplex SAMDI-MS screen reveals novel SARS-CoV-2 3CLpro inhibitors.

Authors:  Michael D Scholle; Patrick T O'Kane; Sandra Dib; Zachary A Gurard-Levin
Journal:  Antiviral Res       Date:  2022-03-09       Impact factor: 5.970

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.